TCG GreenChem

What TCG GreenChem does

TCG GreenChem, Inc. is a US-headquartered pharmaceutical Contract Development and Manufacturing Organization (CDMO) and the US subsidiary of TCG Lifesciences Pvt. Ltd. (formerly Chembiotek Research International), a Contract Research and Manufacturing Services (CRAMS) platform founded in Kolkata, India in 2001. Founded in 2019 by Dr. Chris H. Senanayake (CEO & CSO) and Dr. Joseph D. Armstrong III (COO), the company is incorporated in New Jersey and operates a process R&D center in Ewing (Princeton South) with USFDA-approved cGMP manufacturing capacity at parent-owned facilities in Kolkata and Hyderabad, India. Its product surface centers on two proprietary technology platforms — ARDEL (Automated Reaction Design and Engineering Lab), a high-throughput experimentation engine for catalyst and reaction screening, and CFL (Continuous Flow Technology Lab), which converts batch chemistry into continuous processes for hazardous or extreme-condition reactions — integrated with a broad catalysis toolkit spanning asymmetric catalysis, biocatalysis, C-H activation, hydrocyanation, and more.

The company monetizes through fee-for-service CDMO contracts, providing end-to-end CMC services from process research and development (mg to cGMP scale) through analytical method validation, solid-state characterization, and cGMP API manufacturing for clinical and commercial supply. Customers are global pharmaceutical, biotechnology, and generic-drug companies, with one disclosed customer (Krouzon Pharmaceuticals) and a recent strategic alliance with Indena (2025). Pricing is quote-based and not publicly disclosed, consistent with custom contract-manufacturing engagements.

Go-to-market is enterprise field sales led by a direct business development team, supplemented by industry-conference presence (CPhI North America, ISCCET, ETH Zurich Behringer Simon Lecture) and scientific publication credibility. The 1,300+ scientist talent pool across TCGLS, including 300+ PhDs and leadership with prior tenures at Boehringer Ingelheim, Merck, Sepracor, Syngene, and AstraZeneca, functions as a primary sales asset in a relationship-driven CDMO market.

Name

TCG GreenChem

Legal name

TCG GreenChem, Inc.

Website

https://tcggreenchem.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

TCG GreenChem is a US-based pharmaceutical CDMO and US subsidiary of India's TCG Lifesciences, providing process R&D, continuous flow chemistry, and USFDA-approved cGMP API manufacturing to global pharma, biotech, and generic-drug companies from facilities in New Jersey, Kolkata, and Hyderabad.

Ownership category

akta.pro rank

Product category

Pharmaceutical CDMO Services

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Scientific Research and Development Services (5417), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Services-Commercial Physical & Biological Research (8731), Pharmaceutical Preparations (2834), Services-Testing Laboratories (8734)

akta.pro primary industry

Small-Molecule API & Intermediates CDMO (HLAGABAA)

akta.pro secondary industries

Drug Substance–Drug Product Integrated CDMO (HLAGABAG), Small-Molecule API Commercial Manufacturing (HLAGAHAB), GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL), CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD), Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK)

Keywords

• Contract manufacturing services
• Pharmaceutical CDMO services
• Process research development
• CGMP API manufacturing
• Green chemistry catalysis

Headquarters

HQ city

Trenton

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. CDMO Contract Research and Manufacturing Services: TCG GreenChem provides end-to-end CMC development services from process research and development through cGMP API manufacturing. Revenue is generated through fee-for-service contracts for pharmaceutical R&D, process development, analytical services, and cGMP manufacturing of intermediates and APIs for clinical and commercial supply.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

TCG GreenChem is a pharmaceutical CDMO that provides end-to-end CMC development services from process research and development through cGMP API manufacturing. The company's offerings span process R&D, analytical R&D and quality control, pharmaceutical solid state characterization and crystallization development, analytical method validation, and USFDA-approved cGMP API manufacturing for clinical and commercial supply. It is differentiated by its proprietary ARDEL high throughput experimentation platform and CFL continuous flow chemistry lab, integrated within a US-India manufacturing model serving global pharmaceutical, biotech, and generic industry clients.

Product overview

TCG GreenChem offers an integrated CDMO (Contract Development and Manufacturing Organization) platform combining two core technology labs—ARDEL (Automated Reaction Design and Engineering Lab) and CFL (Continuous Flow Technology Lab)—with comprehensive service offerings spanning the drug development pipeline from process research through cGMP API manufacturing. The company provides process R&D, analytical services, solid state characterization, crystallization development, and US FDA-approved manufacturing capabilities across facilities in New Jersey, USA and India.

Differentiator

Problem solved

Functional benefit

Products and services

• Process Research & Development Scalable synthesis development services for pharmaceutical intermediates and APIs with emphasis on green and sustainable manufacturing processes, supporting clients from process research through scale-up.
• Analytical R&D and Quality Control
• Pharmaceutical Solid State Physicochemical Characterization and Crystallization Development
• Analytical Method Validation (US FDA Certified)
• cGMP API Manufacturing
• ARDEL (Automated Reaction Design and Engineering Lab) and Services
• CFL (Continuous Flow Technology Lab)
• US FDA Approved API Manufacturing Facility
• Flow Chemistry Technology Services
• Drug Product Development

Quantifiable outcome

• Accelerated IND enabling toxicity studies and CMC requirements for Phase I clinical studies, shortening overall drug development timeline
• +1 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core and flagship.

• IndenacoreStrategic or Co-development Partner · 1 January 2025TCG GreenChem and Indena entered into a strategic alliance to solve global CDMO challenges. The partnership combines TCG GreenChem's process chemistry, catalysis, and flow chemistry capabilities with Indena's expertise to offer comprehensive solutions to pharmaceutical clients worldwide. The alliance addresses supply chain resilience and regulatory compliance challenges in the CDMO industry.
• Krouzon PharmaceuticalscoreStrategic or Co-development PartnerKrouzon Pharmaceuticals entered into an R&D and Commercial Manufacturing Agreement with TCG GreenChem Inc. TCG GreenChem will provide research and development services as well as commercial manufacturing capabilities for active pharmaceutical intermediates and APIs on behalf of Krouzon Pharmaceuticals.
• TCG Lifesciences Pvt. Ltd.flagshipOthersTCG GreenChem, Inc. is the US subsidiary of TCG Lifesciences Pvt. Ltd. (formerly Chembiotek Research International), a leading global CRAMS company in drug discovery, development and commercialization. TCG Lifesciences started operations in 2001 in Kolkata, India. The synergy between TCG Lifesciences in India and TCG GreenChem in the USA enables cost arbitrage without compromising quality or speed. TCG Lifesciences also has an FDA-approved facility in Hyderabad (Clininvent) with pilot plant and commercialization suites for APIs.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Cambrex: Established US-headquartered small-molecule API CDMO with multiple manufacturing sites and broader service portfolio—comparable end market (small-molecule API manufacturing) but significantly larger scale and broader capabilities.
• Lonza Group: World's largest CDMO with broad small-molecule API capabilities, flow chemistry, and commercial manufacturing—represents the upper-bound competitor in scale and global reach.
• Curia (formerly AMRI): Global CDMO with API development and manufacturing, drug product services, and integrated CMC offerings—comparable services but broader portfolio including biologics and analytical services.
• WuXi STA (WuXi AppTec): Global CDMO with large-scale small-molecule API manufacturing and integrated CMC services—comparable in service scope but substantially larger capacity and global footprint.

Direct peers

• Syngene International: India-based integrated CRO-CDMO serving global pharma with discovery, development, and manufacturing services. Particularly relevant given TCG GreenChem's Managing Director (Goutam Das) was previously COO of Syngene for 17 years.
• Sai Advantium Pharma (formerly Advinus Therapeutics): India-based CDMO offering integrated drug discovery, process development, and API manufacturing for global innovators—comparable in India-origin, US-India bridge model, and small-molecule focus.
• Sai Life Sciences: India-based CDMO providing process R&D, API manufacturing, and integrated CMC services for global pharma, with strong flow chemistry capabilities—comparable scope, customer base, and India-cost-arbitrage business model.
• Piramal Pharma Solutions: Indian-headquartered CDMO with US-India integrated model and FDA-approved facilities offering small-molecule API development, process R&D, and commercial manufacturing—closely mirroring TCG GreenChem's positioning, scale, and US-India cost arbitrage model.
• Anthem Biosciences: India-based CDMO offering process R&D, custom synthesis, and cGMP API manufacturing with strong scientific leadership—comparable in size, scope, and customer overlap.
• Aragen Life Sciences (formerly GVK Bio): Indian CRDMO with large scientific workforce providing discovery, development, and manufacturing services including small-molecule API—comparable in talent scale, India footprint, and global pharma customer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/tcg-greenchem-inc
• Xx.com/TCGGreenChem

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TCG GreenChem